Physician and Institution Preparedness for CAR-T

As therapies like Kymriah and Yescarta transform medicine, how can you assist in swift uptake of these treatments or ensure success in the development of yours? HRA® is conducting a syndicated study to determine the preparedness of physicians and institutions for CAR-T cell therapy. In this interactive webinar we will discuss:
  • How you can help prepare institutions to provide CAR-T cell therapy
  • How you can educate physicians on the process and side effects
  • Physician concerns about this treatment and how pharma can combat them
Copyright HRA Data Driven Intelligence 1974-2020 HRA Data Driven Intelligence, LLC. All rights Reserved.